Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
University of Texas
Helpful Links
 

61st Pharmacy Practice Seminar • PPS


For detail information regarding PPS, please visit the main website:  http://www.utexas.edu/pharmacy/ce/conferences/pps/index.html

New Registration System this year!  Even though you have been attending PPS for many years, this is a new registration system, so everyone must register as a new user and create a new account this year.  

NOTE:   For final agenda and presentation times, please consult the PPS Agenda by clicking here.

Pharmacy Technician and UT Faculty/Preceptor Discounts:
  • Pharmacy Technicians should use the coupon code:  "technician" in the coupon box on the registration screen to obtain discount.
  • Current UT Austin Preceptors, Faculty, Residents, and Graduate Students should use the coupon code:  "utfacultyin the coupon box on the registration screen to obtain discount. 

 
 

Date: Sep 28, 2013 07:00 AM - Sep 29, 2013 05:00 PM

Fee

$390.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 24, 2013

Target Audience(s)

  • Pharmacists
  • Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

To Receive Continuing Education Credit
 
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit.  In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and return their completed Record of Attendance/Evaluation Forms at the conclusion of the program.
 

 
 

Objectives

  • Recognize how to create patient/consumer friendly environments.
  • Discuss how to deliver safe, patient-centered care in threat-free environments through a greater awareness of safety issues.
  • Critically discuss the “second victim” (healthcare workers involved in adverse events).

Speaker(s)/Author(s)

Ridley Barron

Activity Number

0067-0000-13-029-L05-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.50
Registration Closed  

 
 

Objectives

  • Define and describe changes in community-acquired methicillin-resistant S. aureus (CA-MRSA).
  • Recognize characteristic features of CA-MRSA skin and soft tissue infections.
  • Evaluate CA-MRSA SSTI treatment options.
  • Identify CA-MRSA SSTI strategies for prevention.

Speaker(s)/Author(s)

Russell T. Attridge, PharmD, MS, BCPS
Assistant Professor, Univ. of Incarnate Word Feik School of Pharmacy

Activity Number

0067-0000-13-030-L01-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

 
 

Objectives

  • Review major health IT trends shaping the future of healthcare.
  • Discuss patient perspectives and experiences with emerging health IT
  • Describe the implications of health IT advancements on pharmacy practice

Speaker(s)/Author(s)

Brent I. Fox, Pharm.D., Ph.D.
Associate Professor, Pharmacy Care Systems, Harrison School of Pharmacy, Auburn University

Activity Number

0067-0000-13-031-L04-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.25
Registration Closed  

 
 

Objectives

  • Define basic terms that are necessary to have a conversation about breast cancer with patients.
  • Examine the role genetics play in the treatment of breast cancer.
  • Identify key counseling points that will help patients better manage the side effects of cancer treatment.

Speaker(s)/Author(s)

Carla Portnoy, R.Ph.
Clinical Oncology Pharmacist, Texas Oncology

Activity Number

0067-0000-13-032-L01-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.25
Registration Closed  

 
 

Objectives

  • Differentiate between infectious and non-infectious causes of upper respiratory tract symptoms.
  • Describe the role of antimicrobial therapy and immunizations in the management of URTIs.
  • Provide recommendations for use of OTC medications management of upper respiratory symptoms in infants/children.

Speaker(s)/Author(s)

Elizabeth O. Hand, Pharm.D., BCPS picture

Elizabeth O. Hand, Pharm.D., BCPS
Clinical Assistant Professor - Pediatrics, The University of Texas at Austin College of Pharm


Disclosure : Nothing to disclose

Activity Number

0067-0000-13-034-L01-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

 
 

Objectives

  • Review the history of parental concerns about vaccines.
  • Examine how people make decisions regarding vaccines.
  • Discuss how to communicate factual, evidence-based information about the risks/benefits of vaccines to parents.

Speaker(s)/Author(s)

Ari Brown, M.D., FAAP
Pediatrician, Author, Speaker

Activity Number

0067-0000-13-035-L01-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

 
 

Objectives

  • Identify current trends in pharmaceutical controled substance abuse.
  • Describe common methods of diversion and the resulting negative societal impact.
  • Describe briefly the 2011 Prescription Drug Abuse Prevention Plan, and how pharmacists can play a role.

Speaker(s)/Author(s)

Joseph T. Rannazzisi
Deputy Assistant Administrator - Office of Diversion Control, US Dept of Justice Drug Enforcement Administration

Activity Number

0067-0000-13-036-L04-P/T
Date: 09/28/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.50
Registration Closed  

 
 

Objectives

  • Describe the pathophysiology of fibromyalgia.
  • Describe the characteristic clinical features of fibromyalgia, and the impact on patient health.
  • Describe the multidimensional management of fibromyalgia with pharmacologic and nonpharmacologic therapies

Speaker(s)/Author(s)

Christopher Parker, D.O., FACP, FACR
Rheumatology Service, Austin Diagnostic Clinic

Activity Number

0067-0000-13-037-L01-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

Objectives

  • Cite recent changes in pharmacy laws and rules and their impact on daily practice.

Speaker(s)/Author(s)

Gay Dodson picture

Gay Dodson, R.Ph.
Executive Director / Secretary , Texas State Board of Pharmacy


Disclosure : Gay Dodson has no relevant financial relationships to disclose.

Activity Number

0067-0000-13-038-L03-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

0.75
Registration Closed  

 
 

Objectives

  • Critically discuss practice scenarios regarding Texas pharmacy laws and rules.

Speaker(s)/Author(s)

Gay Dodson picture

Gay Dodson, R.Ph.
Executive Director / Secretary , Texas State Board of Pharmacy


Disclosure : Gay Dodson has no relevant financial relationships to disclose.

Activity Number

0067-0000-13-039-L03-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

0.50
Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses and dosing of selected prescription drugs recently marketed.

Speaker(s)/Author(s)

Leroy C. Knodel picture

Leroy C. Knodel, Pharm.D.
Clinical Professor & Associate Professor, UT Austin College of Pharmacy / UTHSCSA


Disclosure : Leroy C. Knodel has no relevant financial relationships to disclose.

Activity Number

0067-0000-13-040-L04-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.25
Registration Closed  

 
 

Objectives

  • Briefly review the pathophysiology and epidemiology of Hepatitis C.
  • Discuss history of Hepatitis C treatment and current treatment options for Hepatitis C.
  • Discuss long–term prognosis and success rate of current Hepatitis C treatments.
  • Identify key counseling points for side effect management and improved adherence.

Speaker(s)/Author(s)

Shadi Giani, RN, MSN, ACNS-BC
Austin Hepatitis Center

Activity Number

0067-0000-13-041-L01-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

 
 

Objectives

  • Provide a brief overview of types of compounding – from simple non–sterile to complex high risk compounds.
  • Briefly discuss current standards of compounding practice, with highlights of significant and/or common areas of non–compliance.
  • Discuss potential regulatory changes that may occur in the wake of recent compounding related fatalities.
  • Discuss shortcomings with the pharmacy compounding profession.

Speaker(s)/Author(s)

Travis Leeah, R.Ph., MBA
President and Chief Operating Officer, Unique Pharmaceuticals, Ltd.

Activity Number

0067-0000-13-042-L04-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed  

 
 

Objectives

  • List inappropriate OTC medications for older adults.
  • Identify exclusions for self-care for older patients with cough, cold, and allergy symptoms.
  • Recommend OTC treatment options for cough, cold, and allergy symptoms in geriatric patients.

Speaker(s)/Author(s)

G. Blair Sarbacker, Pharm.D.
Assistant Professor, University of the Incarnate Word

Activity Number

0067-0000-13-043-L01-P/T
Date: 09/29/13
Time: 12:00 AM - 12:00 AM

CE Hours

1.00
Registration Closed